Abbott reports third-quarter 2013 results
Abbott today announced financial results for the third quarter ended Sept. 30, 2013. Third-quarter 2013...
Adocia announces its Q1 2013 revenues
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already...
Bristol-Myers Squibb reports first quarter 2013 financial results
Bristol-Myers Squibb Company (NYSE: BMY) reported financial results for the first quarter of 2013,...
Abbott reports first-quarter 2013 results
Abbott announced financial results for the first quarter ended March 31, 2013. Worldwide sales...
Bristol-Myers Squibb to Announce Results for First Quarter 2013 on April 25
Bristol-Myers Squibb Company will announce results for the first quarter of 2013 on Thursday...
A strong cash position of EUR 30.5 million, an annual loss of EUR 6.0...
Adocia, a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved...
Adocia reports 2012 revenue multiplied by 2.5 with a strong cash position
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines with already...
Sanofi delivers solid 2012 results despite patent expirations
In the fourth quarter of 2012, Sanofi generated sales of €8,526 million, an increase...
Roche delivers strong 2012 results
Roche delivered a strong performance in 2012, with Group sales rising 4% to 45.5...
AstraZeneca fourth quarter and full year results 2012
AstraZeneca's revenue in the fourth quarter was down 15 percent at constant exchange rates...
